genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2017
Kidney cancer
Cancer
Acceleron Halts Development of Cancer Candidate Dalantercept
Cancer
New Mouse Model Developed for Investigating Kidney Cancer
Cancer
Immunotherapy Advanced by Immune Cell Studies of Lung and Kidney Cancers
A-Lists
25 Clinical Failures of Q1 2017
Cancer
Argos Says Lead Candidate Likely to Fail Phase III Trial
Cancer
Telix Nabs Wilex’s Radiolabeled mAb for Cancer Imaging and Therapeutic Use
Drug Discovery
Pfizer, NCI to Study Three Cancer Immunotherapy Candidates
Cancer
After RCC Trial Failure, Cerulean to Slash Headcount
Cancer
Large Genomic Study Finds New Kidney Cancer Subtypes and Drug Targets
Cancer
BMS, Five Prime Plan Cancer Combo Trial, in $30M+ Expansion of Alliance
1
2
3
4
...
9
Page 3 of 9
Scroll Up